|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-8-4
|
|
pubmed:abstractText |
Adult patients with GH deficiency (GHD) are at increased risk for cardiovascular morbidity and mortality. Endothelial function, vascular stiffness, and loss of circulating CD34+ cells are considered biomarkers for cardiovascular disease. The aim of this study was to assess vascular structure and function in relation to circulating CD34+ cells in adults with GHD before and during 1 year of recombinant human GH (rhGH) replacement.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1479-683X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
159
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
105-11
|
|
pubmed:meshHeading |
pubmed-meshheading:18495694-Adult,
pubmed-meshheading:18495694-Aged,
pubmed-meshheading:18495694-Antigens, CD34,
pubmed-meshheading:18495694-Blood Cell Count,
pubmed-meshheading:18495694-Blood Cells,
pubmed-meshheading:18495694-Dwarfism, Pituitary,
pubmed-meshheading:18495694-Endothelium, Vascular,
pubmed-meshheading:18495694-Female,
pubmed-meshheading:18495694-Hematopoietic Stem Cells,
pubmed-meshheading:18495694-Hormone Replacement Therapy,
pubmed-meshheading:18495694-Human Growth Hormone,
pubmed-meshheading:18495694-Humans,
pubmed-meshheading:18495694-Male,
pubmed-meshheading:18495694-Middle Aged,
pubmed-meshheading:18495694-Recombinant Proteins
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Recombinant human GH replacement increases CD34+ cells and improves endothelial function in adults with GH deficiency.
|
|
pubmed:affiliation |
Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. a.a.van_der_klaauw@lumc.nl
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
